10
Dec
2024

Medical Union Pharmaceuticals

Exhibitor at CPHI Middle East 2024 stand 1.B27
About Us

MUP established in 1984 to develop regional pharmaceutical market.​

MUP becomes leading international pharmaceutical company, generating revenue of around 2.4 Billion LE in 2018. We have a balanced business model for sustainability, covering branded generics and biosimilar that are well diversified by geography and product. We have operations in more than 40 countries across three continents, employing 2,357 people globally.​
We develop, manufacture and market a broad range of branded and non-branded generic pharma...

Read more Show less
Categories
more categories Show less
  • EG
  • 2020
    On CPHI since
  • 1000 - 4999
    Employees
View company profile
Contact info
  • +20222737061
  • 37 Dr. Mohamed Hassan El Gamal, 6th District, Nasr City, Cairo, Egypt
Show contact info Hide contact info
Event information
CPHI Middle East 2024
  • 10 Dec 2024 - 12 Dec 2024
  • Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
  • Visit us at stand 1.B27

Products Featured at CPHI Middle East 2024

  • Insulinaegypt

    Product Insulinaegypt

    Active ingredient: Insulin human injection 
    Indication: Hypoglycemic Agent 

    Forms:    Vails & Cartilages

    Doses:   Insulinagypt N 100 IU
                   Insulinagypt R 100 IU ...
  • Davalindi Tablet

    Product Davalindi Tablet

    Active ingredient: 10 mg Cholecalciferol Concetrate (100.00 IU/g) equivalent to (1000 IU) cholecalciferol (vit. D3) 
    Indication: Vit. D3 supplement, treatment of rickets and osteoporosis 


    Forms: Tablet


    Pack Size: 100 tab 
  • Dexamethasone

    Product Dexamethasone

    Active ingredient: 8 mg Dexamethasone Phosphat / 2 ml Amp.        

    Indication: Systemic Corticosteroid 


    Forms: Ampoule
  • Levanic

    Product Levanic

    Active ingredient:  Levofluxacin

    Indication: Broad-Spectrum Antibiotic ( Quinolone Group )


    Forms: Levanic 500 mg Tablet
                Levanic 750 mg Tablet
  • Mobitil

    Product Mobitil

    Active ingredient: Meloxicam 

    Indication: Non steroidal Anti-inflammatory, analgesic 


    Forms: Tab, Amp and suppositories 


    Doses:  Mobitil  15 mg Supp, Mobitil  7.5mg Tab, Mobitil  15 mg Tab, Mobitil  15 mg Ampoule
  • Pantoloc Tablet

    Product Pantoloc Tablet

    Active ingredient:  Pantoprazole ( as Pantoprazole Sodium Sesquihydrate)
    Indication: Treatment of reflux oesophagitis, gastric & duodenal ulcers, Zollinger - Ellison Syndrome


    Forms: Pantoloc  20 mg Tablet
                &n...
  • Silvirburn

    Product Silvirburn

    Active ingredient: 10 mg Silver sulfadiazine / 1 gm 

    Indication: For prophylaxis and treatment of infection in burn wounds   


    Forms: Cream and Aerosol 
  • Unictam

    Product Unictam

    Active ingredient: Ampicillin  Sulbactam

    Indication: Upper Respiratory tract infections and Lower respiratory tract infections 


    Forms: Vial, Tab and Suspension 


    Doses: Unictam Vail 375 mg
                 Unictam V...
  • Vidrop

    Product Vidrop

    Active ingredient: 1 Drop = 100 I.U.Vit D3 (Colecalciferol)
    Indication: Vit. D3 supplement, treatment of rickets and osteoporosis


    Forms: Oral Drpos 

  • Xoraxon

    Product Xoraxon

    Active ingredient: Ceftriaxone Sodium

    Indication: Lower RT inf., Acute Bacterial 


    Forms: Vial


    Doses: Xoraxon Vial 0.5 mg Vial (I/V)
                Xoraxon Vial 1 gm Vial (I/V)
             ...